PHR1817
Furosemide Related Compound A
Pharmaceutical Secondary Standard; Certified Reference Material
Synonyme(s) :
2-Chloro-4-furfurylamino-5-sulfamoylbenzoic acid, 2-CHLORO-4-N-FURFURYLAMINO -5-SULFAMOYLBENZOIC ACID
About This Item
Produits recommandés
Qualité
certified reference material
pharmaceutical secondary standard
Niveau de qualité
Agence
traceable to Ph. Eur. F0702000
traceable to USP 1287020
CofA (certificat d'analyse)
current certificate can be downloaded
Conditionnement
pkg of 100 mg
Pf
197 °C (dec.) (lit.)
Application(s)
pharmaceutical
Format
neat
Température de stockage
2-30°C
Chaîne SMILES
OC(C1=C(Cl)C=C(NCC2=CC=CO2)C(S(N)(=O)=O)=C1)=O
InChI
1S/C12H11ClN2O5S/c13-9-5-10(15-6-7-2-1-3-20-7)11(21(14,18)19)4-8(9)12(16)17/h1-5,15H,6H2,(H,16,17)(H2,14,18,19)
Clé InChI
UXOOVYKVEXGCSH-UHFFFAOYSA-N
Vous recherchez des produits similaires ? Visite Guide de comparaison des produits
Description générale
Application
- Furosemide Impurity A for Quality Control: Furosemide Related Compound A serves as a crucial standard in pharmaceutical quality control, ensuring the purity and safety of furosemide as an active pharmaceutical ingredient. This impurity standard is essential for regulatory compliance and batch-to-batch consistency in drug manufacturing (Abasilim et al., 2023).
- Research on Drug Resistance: Furosemide Related Compound A is utilized in genomic research to identify potential drug resistance mechanisms. This research aids in understanding how bacterial pathogens develop resistance to drugs like clarithromycin and rifampicin, which is crucial for developing new therapeutic strategies (Mofidifar et al., 2024).
- Nanotechnology in Drug Delivery: High-purity Furosemide Related Compound A is used in the preparation and characterization of novel drug delivery systems, such as nanoparticles designed to enhance the bioavailability and efficacy of pharmaceutical compounds. This research highlights its application in improving drug formulations and targeting specific disease sites (Zeng et al., 2024).
- Impact on Bone Health: Research involving Furosemide Related Compound A explores its effects on bone health, particularly in how it influences vitamin D metabolism and bone density. This is vital for developing treatments that mitigate bone density loss associated with long-term use of diuretics like furosemide (Melanie KF et al., 2024).
- Nutritional Studies in Cancer Therapy: Furosemide Related Compound A is also examined for its role in nutritional interventions in cancer therapy, particularly its impact on the nutritional status of patients undergoing surgery for colorectal cancer. These studies are crucial for understanding how nutritional support can enhance recovery and treatment outcomes in cancer patients (Ural et al., 2024).
Remarque sur l'analyse
Autres remarques
Note de bas de page
Produits recommandés
Code de la classe de stockage
11 - Combustible Solids
Classe de danger pour l'eau (WGK)
WGK 3
Point d'éclair (°F)
Not applicable
Point d'éclair (°C)
Not applicable
Choose from one of the most recent versions:
Certificats d'analyse (COA)
Don't see the Right Version?
If you require a particular version, you can look up a specific certificate by the Lot or Batch number.
Déjà en possession de ce produit ?
Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.
Les clients ont également consulté
Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..
Contacter notre Service technique